Displaying results 61 - 72 of 241
General Hepatology
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease among a general population with metabolic dysfunction

Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease among a general p...

ePosters
View
General Hepatology
NT-proBNP levels ?orrelate with liver fibrosis in MASLD patients

NT-proBNP levels ?orrelate with liver fibrosis in MASLD patients

ePosters
View
General Hepatology
Non-invasive parameters compared to FibroScan for the assessment of liver stiffness and controlled attenuation parameters in patients with fatty liver disease

Non-invasive parameters compared to FibroScan for the assessment of liver stiffness and controlled attenuation parameters in p...

ePosters
View
General Hepatology
Morphological changes in liver cirrhosis on imaging and associations to clinical parameters, liver stiffness, steatosis and etiology

Morphological changes in liver cirrhosis on imaging and associations to clinical parameters, liver stiffness, steatosis and et...

ePosters
View
General Hepatology
Hepatocyte-derived extracellular vesicles carrying miR-21 trigger muscle cell dysfunction

Hepatocyte-derived extracellular vesicles carrying miR-21 trigger muscle cell dysfunction

ePosters
View
General Hepatology
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in four cities in the United States, including among people with diabetes and primary care providers

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in four cities in the United States, including a...

ePosters
View
General Hepatology
Unveiling the hidden link: Psoriasis and liver disease risk

Unveiling the hidden link: Psoriasis and liver disease risk

ePosters
View
General Hepatology
10 year progression of metabolic risk factors - correlation with steatosis and fibrosis degree in a general population cohort

10 year progression of metabolic risk factors - correlation with steatosis and fibrosis degree in a general population cohort

ePosters
View
General Hepatology
Does cardiovascular risk differ with age-specific body composition in women with in metabolic dysfunction-associated steatotic liver disease?

Does cardiovascular risk differ with age-specific body composition in women with in metabolic dysfunction-associated steatotic...

ePosters
View
General Hepatology
Multidisciplinary management combining hepatologist counseling, cognitive/behavioral therapy, and nutritional support (the CoCoNut protocol) improves the clinical outcomes of MASLD patients

Multidisciplinary management combining hepatologist counseling, cognitive/behavioral therapy, and nutritional support (the CoC...

ePosters
View
General Hepatology
Circulating EV-miRs for the diagnosis and staging of MASLD and hepatocellular carcinoma

Circulating EV-miRs for the diagnosis and staging of MASLD and hepatocellular carcinoma

ePosters
View
General Hepatology
Effect of diabetes treatment and antilipidemic drugs on metabolic dysfunction-associated steatotic liver disease in type 2 diabetic patients

Effect of diabetes treatment and antilipidemic drugs on metabolic dysfunction-associated steatotic liver disease in type 2 dia...

ePosters
View
Displaying results 61 - 72 of 241